Exploring Ketamine’s Scientific Breakthrough in Severe Depression and Bipolar Disorder

In recent years, the use of ketamine, an old anesthesia drug, for treating severe depression has transitioned from a novel idea to a widely accepted practice. However, as the application of ketamine broadens, numerous questions about its efficacy, patient suitability, and the balance of costs versus benefits remain. 

New research aims to shed light on these areas, offering hope and guidance for those grappling with treatment-resistant forms of depression and bipolar disorder.

Ketamine, initially known for its use in anesthesia, has shown remarkable efficacy in alleviating severe depression symptoms, especially in individuals for whom other treatments have failed. Clinics across the United States have started offering ketamine infusions, with some providing a newer, nasal spray version. Despite its growing popularity, the question of why ketamine benefits some patients significantly while leaving others unchanged persists...<<<Read More>>>...